International Clinical Trial: Artificial Intelligence-Assisted Laxative Dose Reduction in High-Risk Patients With Difficult Bowel Preparation

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115089) titled 'Artificial Intelligence-Assisted Laxative Dose Reduction in High-Risk Patients With Difficult Bowel Preparation' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Xiamen Chang Gung Hospital

Condition: Lower Gastrointestinal Diseases

Intervention: Standard Self-Assessment Group (SP Group):Take the standard 3L polyethylene glycol (PEG) and complete the intestinal preparation using the traditional self-assessment method.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Standard Self-Assessment Group (SP Group...